LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.031667
 27.49 27.76 1972 1723 1.1444 1.0458
MN20160318_Q01
I15
MCF 10A-H2B-mCherry Dasatinib
0.031667
 27.49 27.76 1734 1723 1.0063 1.0021
MN20160318_Q01
M03
MCF 10A-H2B-mCherry Dasatinib
0.031667
 27.49 27.76 1793 1723 1.0405 1.0134
MN20160318_Q01
M03
MCF 10A-H2B-mCherry Dasatinib
0.031667
 29.19 27.76 27 1863 0.0145 -0.0046
MN20160318_Q01
I15
MCF 10A-H2B-mCherry Dasatinib
0.031667
 29.19 27.76 2114 1863 1.1346 1.0421
MN20160318_Q01
I15
MCF 10A-H2B-mCherry Dasatinib
0.031667
 29.19 27.76 1826 1863 0.9801 0.9934
MN20160318_Q01
M03
MCF 10A-H2B-mCherry Dasatinib
0.031667
 29.19 27.76 1909 1863 1.0246 1.0080
MN20160318_Q01
M03
MCF 10A-H2B-mCherry Dasatinib
0.031667
 30.90 27.76 37 2032 0.0182 0.0475
MN20160318_Q01
I15
MCF 10A-H2B-mCherry Dasatinib
0.031667
 30.90 27.76 2302 2032 1.1327 1.0406
MN20160318_Q01
I15
MCF 10A-H2B-mCherry Dasatinib
0.031667
 30.90 27.76 1912 2032 0.9408 0.9804
MN20160318_Q01
M03
MCF 10A-H2B-mCherry Dasatinib
0.031667
 30.90 27.76 1987 2032 0.9777 0.9927
MN20160318_Q01
M03
MCF 10A-H2B-mCherry Dasatinib
0.031667
 32.60 27.76 58 2235 0.0259 0.1234
MN20160318_Q01
I15
MCF 10A-H2B-mCherry Dasatinib
0.031667
 32.60 27.76 2486 2235 1.1119 1.0338
MN20160318_Q01
I15
MCF 10A-H2B-mCherry Dasatinib
0.031667
 32.60 27.76 2055 2235 0.9191 0.9735
MN20160318_Q01
M03
MCF 10A-H2B-mCherry Dasatinib
0.031667
 32.60 27.76 2134 2235 0.9544 0.9853
MN20160318_Q01
M03
MCF 10A-H2B-mCherry Dasatinib
0.031667
 34.30 27.76 64 2449 0.0261 0.1380
MN20160318_Q01
I15
MCF 10A-H2B-mCherry Dasatinib
0.031667
 34.30 27.76 2667 2449 1.0887 1.0265
MN20160318_Q01
I15
MCF 10A-H2B-mCherry Dasatinib
0.031667
 34.30 27.76 2196 2449 0.8964 0.9664
MN20160318_Q01
M03
MCF 10A-H2B-mCherry Dasatinib
0.031667
 34.30 27.76 2302 2449 0.9397 0.9808
MN20160318_Q01
M03
MCF 10A-H2B-mCherry Dasatinib
0.031667
 36.01 27.76 57 2662 0.0214 0.1155
MN20160318_Q01
I15
MCF 10A-H2B-mCherry Dasatinib
0.031667
 36.01 27.76 2775 2662 1.0421 1.0126
MN20160318_Q01
I15
MCF 10A-H2B-mCherry Dasatinib
0.031667
 36.01 27.76 2317 2662 0.8701 0.9582
MN20160318_Q01
M03
MCF 10A-H2B-mCherry Dasatinib
0.031667
 36.01 27.76 2423 2662 0.9099 0.9715
MN20160318_Q01
M03
MCF 10A-H2B-mCherry Dasatinib
0.031667
 37.71 27.76 84 2877 0.0292 0.1798
MN20160318_Q01
I15
MCF 10A-H2B-mCherry Dasatinib
0.031667
 37.71 27.76 3049 2877 1.0595 1.0174
MN20160318_Q01
I15